{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:43:46Z","timestamp":1791189826566,"version":"4.1.0"},"reference-count":21,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3892\/or.2012.1890","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T06:05:32Z","timestamp":1340949932000},"page":"903-908","source":"Crossref","is-referenced-by-count":67,"title":["Metformin inhibits the development and metastasis of ovarian cancer"],"prefix":"10.3892","volume":"28","author":[{"given":"BUCHU","family":"WU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHU","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILI","family":"SHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIYING","family":"GU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAORAN","family":"SHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DUANDUAN","family":"LA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRETT D.","family":"HAMBLY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHISAN","family":"BAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN","family":"DI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"key20180107215251_b1-or-28-03-0903","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"key20180107215251_b2-or-28-03-0903","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2006.02.037","article-title":"Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo","volume":"103","author":"Zhang","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107215251_b3-or-28-03-0903","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-2215-3-8","article-title":"The detection, treatment, and biology of epithelial ovarian cancer","volume":"3","author":"Gubbels","year":"2010","journal-title":"J Ovarian Res"},{"key":"key20180107215251_b4-or-28-03-0903","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180107215251_b5-or-28-03-0903","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"key20180107215251_b6-or-28-03-0903","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"key20180107215251_b7-or-28-03-0903","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-2187-3-18","article-title":"Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1","volume":"3","author":"Zhuang","year":"2008","journal-title":"J Mol Signal"},{"key":"key20180107215251_b8-or-28-03-0903","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"key20180107215251_b9-or-28-03-0903","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180107215251_b10-or-28-03-0903","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","article-title":"Metformin is a potent inhibitor of endometrial cancer cell proliferation - implications for a novel treatment strategy","volume":"116","author":"Cantrell","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107215251_b11-or-28-03-0903","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107215251_b12-or-28-03-0903","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107215251_b13-or-28-03-0903","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107215251_b14-or-28-03-0903","first-page":"233","article-title":"Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization","volume":"18","author":"Shenhua","year":"1999","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107215251_b15-or-28-03-0903","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1525-1438.2006.00547.x","article-title":"Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1","volume":"16","author":"Zhang","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107215251_b16-or-28-03-0903","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/icb.2011.4","article-title":"Gp91(phox) contributes to the development of experimental inflammatory bowel disease","volume":"89","author":"Bao","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"key20180107215251_b17-or-28-03-0903","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/cr.2008.310","article-title":"The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation","volume":"18","author":"Xu","year":"2008","journal-title":"Cell Res"},{"key":"key20180107215251_b18-or-28-03-0903","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","article-title":"Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model","volume":"113","author":"Phoenix","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107215251_b19-or-28-03-0903","first-page":"347","article-title":"Tumor angiogenesis: a quantitative method for histologic grading","volume":"48","author":"Brem","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"key20180107215251_b20-or-28-03-0903","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.176.4.1165","article-title":"Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells","volume":"176","author":"Jonjic","year":"1992","journal-title":"J Exp Med"},{"key":"key20180107215251_b21-or-28-03-0903","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.1890\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:53:02Z","timestamp":1515343982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.1890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6,29]]},"published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.3892\/or.2012.1890"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.1890","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}